Concept information
Preferred term
Oxidopamine
Type
-
mesh:Descriptor
Definition
- A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
Broader concept
Entry terms
- 1199-18-4 (Oxidopamine)
- 1,2,4-Benzenetriol, 5-(2-aminoethyl)-
- 28094-15-7 (HCl)
- 636-00-0 (HBr)
- 6-Hydroxydopamine
- 6-OHDA
- 8HW4YBZ748
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
1,2,4-Benzenetriol, 5-(2-aminoethyl)-
-
1199-18-4 (Oxidopamine)
-
28094-15-7 (HCl)
-
636-00-0 (HBr)
-
8HW4YBZ748
URI
http://data.loterre.fr/ark:/67375/JVR-NLST8VS4-S
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}